Research Progresses in Understanding the Pathophysiology of Moyamoya Disease. Bersano A, Guey S, Bedini G, Nava S, Hervé D, Vajkoczy P, Tatlisumak T, Sareela M, van der Zwan A, Klijn CJ, Braun KP, Kronenburg A, Acerbi F, Brown MM, Calviere L, Cordonnier C, Henon H, Thines L, Khan N, Czabanka M, Kraemer M, Simister R, Prontera P, Tournier-Lasserve E, Parati E; European Moyamoya Disease Initiative. Cerebrovasc Dis. 2016;41(3-4):105-18. doi: 10.1159/000442298. Review.
Analysis of ACTA2 in European Moyamoya disease patients. Roder C, Peters V, Kasuya H, Nishizawa T, Wakita S, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B. Eur J Paediatr Neurol. 2011 Mar;15(2):117-22. doi: 10.1016/j.ejpn.2010.09.002. Epub 2010 Oct 20.
Genetics of Moyamoya disease. Roder C, Nayak NR, Khan N, Tatagiba M, Inoue I, Krischek B. J Hum Genet. 2010 Nov;55(11):711-6. doi: 10.1038/jhg.2010.103. Epub 2010 Aug 26.
Četiri međunarodno priznata stručnjaka za moyamoyu objedinila su svoje široko znanje u opsežnoj stručnoj knjizi «Moyamoya Disease, Diagnosis and Treatment» u kojoj naglašavaju ključne elemente za dijagnosticiranje i liječenje moyamoye.